WW International (WW) shares surged more than 20% in early trading on Wednesday after Morgan Stanley said the company's ...

In a report released today, Alex Fuhrman from Craig-Hallum maintained a Hold rating on WW International (WW – Research Report), with a ...

Despite subscriber declines, WW International Inc (WW) reports strong clinical revenue growth and strategic cost-saving ...

WW International (WW – Research Report), the Consumer Cyclical sector company, was revisited by a Wall Street analyst yesterday. Analyst Nathan Feather from Morgan Stanley maintained a Hold rating on ...

WW International (NASDAQ:WW), more commonly known as WeightWatchers, will now offer compounded semaglutide to its ...

WW International has removed CEO Sima Sistani from the chief executive role effective immediately, the company previously ...

Shares of WeightWatchers parent company WW International ($WW) have rocketed 40% higher on news that the company plans to ...

WW International Inc (WW) stock saw a modest uptick, ending the day at $0.75 which represents a slight increase of $0.03 or 4.17% from the prior close of $0.72. The stock opened at $0.73 and touched a ...

Shares of WW International Inc., known as WeightWatchers, soared 60% early Wednesday to extend their prior-day gains that came after the weight-management company announced the addition of compounded ...

The executive led the diet company, better known as WeightWatchers, since 2022 into the burgeoning market for obesity drugs.

Shares of WW International, better known as WeightWatchers, soared Tuesday after it said it is offering copycat weight-loss drugs to its members.

WeightWatchers recently announced the inclusion of compounded semaglutide into its suite of offerings. This new clinical weight management intervention aims to broaden access for eligible members who ...